2024-10-11 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, consumables, and services for research, analysis, discovery, and diagnostics.

**1. Performance Comparison:**

* **Cumulative Return:** TMO: 242.4% vs. S&P 500 (VOO): 134.82%
* **Deviation:**  TMO is currently outperforming S&P 500 by 111.13% (51.35% relative deviation). This indicates that TMO has significantly outperformed the broader market over time.

**2. Recent Price Movements:**

* **Closing Price:** $599.25
* **5-day Moving Average:** $598.62
* **20-day Moving Average:** $609.45
* **60-day Moving Average:** $602.64

TMO is currently trading slightly below its 5-day moving average, indicating potential short-term downward pressure. However, it is still above its 20-day and 60-day moving averages, suggesting a longer-term uptrend.

**3. Technical Indicators:**

* **RSI:** 35.05
* **PPO:** -0.4
* **Delta_Previous_Relative_Divergence:** -9.64 (Short-term downward trend)
* **Expected Return:** 64.34% (Potential 5-year return exceeding S&P 500)

The RSI indicates that TMO is currently in oversold territory, suggesting potential for a rebound. The negative PPO and the downward trend in the relative divergence signal some short-term weakness. However, the high expected return based on historical performance remains positive.

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | $10.54B |
| 2024-05-03 | 3.47 | $10.35B |
| 2023-11-03 | 4.44 | $10.57B |
| 2023-08-04 | 3.53 | $10.69B |
| 2024-08-02 | 3.53 | $10.69B |

The most recent earnings report for the quarter ended August 2nd, 2024, showed a strong EPS of $4.05, exceeding analyst estimates. Revenue also remained strong, exceeding $10.54B. This indicates continued robust performance for the company. 

**5. News and Recent Events:**

* **Recent Market Outlook:** TMO continues to benefit from strong demand in the life sciences and healthcare sectors. Its focus on consumables and services, combined with its global reach, positions it favorably for growth.
* **Analyst Opinions:** Most analysts maintain a bullish outlook on TMO, citing its consistent financial performance and strong growth potential.
* **Performance Highlights:**  TMO has a long history of exceeding market expectations and delivering consistent returns. Recent acquisitions and investments in innovation further solidify its leadership position.

**6. Summary & Conclusion:**

Thermo Fisher Scientific Inc. (TMO) is a high-performing company with a strong track record. While recent price movements indicate some short-term pressure, its long-term growth potential remains robust. The company's strong earnings and continued focus on innovation suggest continued success in the future. Investors seeking long-term exposure to the life sciences and healthcare sectors may find TMO an attractive investment opportunity.

**7. Further Research:**

* Analyze TMO's financial statements, specifically its balance sheet and cash flow statements.
* Evaluate the company's competitive landscape and its ability to maintain its market share.
* Consider the potential impact of regulatory changes and evolving industry trends on TMO's future performance.

**Disclaimer:** This information is for educational purposes only and should not be considered financial advice.  Please consult with a qualified financial advisor before making any investment decisions. 
